encyclopedia of medical concepts
ψ
Dopa Decarboxylase
More information
in Books
or on
Definition
: One of the AROMATIC-L-AMINO-ACID DECARBOXYLASES, this enzyme is responsible for the conversion of dopa to dopamine. It is of clinical importance in the treatment of Parkinson's disease. EC 4.1.1.28.
Other names
Decarboxylase, Dopa
Substance
CAS Registry & name
Categories
Source
Drugs
*
TyDC5 protein, Papaver somniferum
EC 4.1.1.-
*Dopa Decarboxylase
*Plant Proteins
*Tyrosine Decarboxylase.
Plant Physiol 1996 Jan;110(1):43-9
2,3-
methano-
3-
tyrosine
139561-05-0
Tyrosine/*analogs & derivatives
Dopa Decarboxylase/antagonists & inhibitors.
J Med Chem 1992 Apr 17;35(8):1410-17
NSD 1034
555-62-4 3-
((1-
methylhydrazino)methyl)phenol
*Hydrazines
Dopa Decarboxylase/antagonists & inhibitors.
Biochem Pharmacol 28(7):1029;1979
5-
(3,4-
dihydroxycinnamoyl)salicylic acid
0
*Salicylic Acids
Dopa Decarboxylase/antagonists & inhibitors.
J Neurochem 28:361;1977
2,3,4-
trihydroxybenzylhydrazine
3614-72-0 1,2,3-
Benzenetriol, 4-
(hydrazinomethyl)
*Hydrazines
Dopa Decarboxylase/antagonists & inhibitors.
Rev Prat (Paris) 24(15):1212;1974
3-
hydroxybenzylhydrazine
637-33-2 3-
(hydrazinomethyl)phenol
*Hydrazines
Dopa Decarboxylase/antagonists & inhibitors.
Pharma Action
Enzyme Inhibitors
Allergy 34(2):103;1979; Brain Res 131(2):313;1977; Catecholamines & Stress W3 19916p:18;1975c; Endocrinology 1980;106(2):463; J Neural Transm 1979;46(3):184; J Neural Transm 1979;46(4):263; J Neural Transm 1980;47(1):1; J Neurochem 1980;34(4):933; Naunyn Schmiedebergs Arch Pharmacol 286:389;1975; Naunyn Schmiedebergs Arch Pharmacol 290(4):347;1975; Naunyn Schmiedebergs Arch Pharmacol 292(2):167;1976; Psychopharmacology 51(3):293;1977